Andi Tate

Andi Tate is an accomplished professional with extensive experience in project management within the biopharmaceutical industry, currently serving as Executive Director and Business Segment Lead for Respiratory Vaccines at PPD since December 2016. With a career that spans over two decades, Andi has held various leadership roles at notable organizations such as PATH, Seattle Genetics, Amgen, Targeted Genetics, and Abbott Laboratories. Andi's expertise encompasses managing complex global projects, conducting risk assessments, and leading cross-functional teams in strategic planning and execution. Educational credentials include an MBA in Technology Management from the UW Foster School of Business and a B.S. in Medical Technology from Northern Illinois University.